It seems there are some plans to get Relenza intravenous moving...

It seems there are some plans to get Relenza intravenous moving by top physicians who must know it damn works. GSK should go full steam a head market Relenza + intravenous save the World pay its debt to Biota and still come up trumps IMO because at the moment they losing ground big time.




"They'll tell us what's been done and what's happened. That may allow one to say: 'This does not work and we shouldn't be doing this.' That's sometimes just as important as saying: 'This does work,"' Hayden notes.

In addition to learning about past cases, gathering together the physicians who have treated H5N1 cases in 12 countries should enhance research collaborations - including planned clinical trials of intravenous forms of two antiviral drugs - zanamivir (sold as Relenza) and peramivir, a drug still in development.

(GlaxoSmithKline, which makes Relenza, has shelved plans to test an intravenous form of the drug in the United States, but is in discussions with a WHO-organized treatment network in Southeast Asia to test the new formulation there.)

http://bodyandhealth.canada.com/channel_health_news_details.asp?news_id=11900&news_channel_id=1020&channel_id=1020&rot=11